# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA4171241 | 5g | Ratio CC50/EC50 | = | 4.7 | ALA5135907 | ||||||
2. | ALA4171241 | 5g | EC50 | = | 1.7 | uM | ALA5135906 | 5.77 | nM | |||
3. | ALA4171241 | 5g | Ratio CC50/EC50 | = | 25.6 | ALA5135905 | ||||||
4. | ALA4171241 | 5g | EC50 | = | 0.3 | uM | ALA5135904 | 6.52 | nM | Human coronavirus 229E | ||
5. | ALA4171241 | 5g | Ratio CC50/EC50 | = | 4.3 | ALA5135903 | ||||||
6. | ALA4171241 | 5g | CC50 | = | 30.3 | uM | ALA5135902 | nM | Chlorocebus sabaeus | |||
7. | ALA4171241 | 5g | EC50 | = | 7.1 | uM | ALA5135901 | 5.15 | nM | Severe acute respiratory syndrome coronavirus 2 | ||
8. | ALA4171241 | 5g | CC50 | = | 8 | uM | ALA5135900 | nM | Homo sapiens | |||
9. | ALA4171241 | 5g | MIC | 0 | ALA4151532 | Not Determined | Staphylococcus aureus | |||||
10. | ALA4171241 | 5g | MIC | 0 | ALA4151531 | Not Determined | Staphylococcus aureus | |||||
11. | ALA4171241 | 5g | MIC | 0 | ALA4151530 | Not Determined | Staphylococcus aureus | |||||
12. | ALA4171241 | 5g | MIC | 0 | ALA4151529 | Not Determined | Staphylococcus aureus | |||||
13. | ALA4171241 | 5g | MIC | > | 100 | ug ml-1 | ALA4151528 | ug.mL-1 | Staphylococcus aureus | |||
14. | ALA4171241 | 5g | MIC | > | 100 | ug ml-1 | ALA4151525 | ug.mL-1 | Staphylococcus aureus | |||
15. | ALA4171241 | 5g | CC50 | 0 | ALA4151524 | Not Determined | Homo sapiens | |||||
16. | ALA4171241 | 5g | CC50 | 0 | ALA4151523 | Not Determined | Homo sapiens | |||||
17. | ALA4171241 | 5g | INH | 0 | ALA4151517 | Active | % | Staphylococcus aureus | ||||
18. | ALA4171241 | 5g | INH | 0 | ALA4151516 | Active | % | Staphylococcus aureus | ||||
19. | ALA4171241 | 5g | INH | 0 | ALA4151515 | Active | % | Staphylococcus aureus | ||||
20. | ALA4171241 | 5g | Activity | = | 25 | ug ml-1 | ALA4151514 | ug ml-1 | Staphylococcus aureus |